Skip to main content
logo
Enorama Pharma AB (publ) (STO:ERMA)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.7500
-0.0160 (-2.09%)
Nov 5, 2026, 5:25 PM CET

Enorama Pharma AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
5614220311428171
Market Cap Growth
-73.21%-29.89%77.51%308.04%-83.60%-12.51%
Enterprise Value
5413619410827171
Last Close Price
0.771.913.362.512.9517.98

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
38.6652.0112.8984.294.1015.50
PB Ratio
--6.0726.045.860.898.01
P/TBV Ratio
--26.045.860.898.01

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
37.2149.6212.3079.673.8815.53

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
---0.020.060.18
Net Debt / Equity Ratio
0.040.13-0.27-0.29-0.07-0.39
Net Debt / EBITDA Ratio
0.040.050.070.140.050.32
Net Debt / FCF Ratio
0.040.050.060.140.070.28
Asset Turnover
0.090.230.630.030.140.24
Inventory Turnover
2.492.731.551.483.666.03
Quick Ratio
0.120.180.430.800.681.77
Current Ratio
0.210.251.871.270.951.92
Return on Equity (ROE)
---320.44%-174.74%-158.97%-239.87%
Return on Assets (ROA)
-213.34%-321.44%-75.83%-62.91%-52.64%-37.20%
Return on Capital Employed (ROCE)
211.30%264.90%-390.90%-173.10%-115.60%-69.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-111.14%-52.74%-21.56%-38.97%-149.82%-16.22%
FCF Yield
-94.83%-41.60%-17.57%-36.12%-117.48%-17.67%
Buyback Yield / Dilution
-21.21%-30.99%-91.50%-253.96%-26.23%-11.44%